Mealey's (January 6, 2017, 7:21 AM EST) -- WASHINGTON, D.C. — Johnson & Johnson Vision Care Inc. (JJVC) argues in a Dec. 27 reply brief that the U.S. Supreme Court should consider whether the Federal Circuit U.S. Court of Appeals erred in granting Rembrandt Vision Technologies LP a new trial based on an expert’s false testimony over alleged infringement of its contact lens patent (Johnson & Johnson Vision Care Inc. v. Rembrandt Vision Technologies LP, No. 16-489, U.S. Sup.)....